Baird Medical Investment Holdings/$BDMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Baird Medical Investment Holdings
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.
Ticker
$BDMD
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
143
ISIN
KYG0705H1039
Website
BDMD Metrics
BasicAdvanced
$173M
13.24
$0.49
-0.93
-
Price and volume
Market cap
$173M
Beta
-0.93
52-week high
$7.10
52-week low
$3.30
Average daily volume
60K
Financial strength
Current ratio
1.774
Quick ratio
1.44
Long term debt to equity
9.002
Total debt to equity
52.508
Interest coverage (TTM)
26.55%
Profitability
EBITDA (TTM)
16.454
Gross margin (TTM)
88.16%
Net profit margin (TTM)
33.62%
Operating margin (TTM)
41.35%
Effective tax rate (TTM)
10.57%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
14.22%
Return on equity (TTM)
33.39%
Valuation
Price to earnings (TTM)
13.236
Price to revenue (TTM)
4.45
Price to book
4.16
Price to tangible book (TTM)
4.16
Price to free cash flow (TTM)
-17.981
Free cash flow yield (TTM)
-5.56%
Free cash flow per share (TTM)
-35.87%
Growth
Revenue change (TTM)
17.74%
Earnings per share change (TTM)
18.86%
3-year revenue growth (CAGR)
12.74%
3-year earnings per share growth (CAGR)
283.94%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Baird Medical Investment Holdings stock?
Baird Medical Investment Holdings (BDMD) has a market cap of $173M as of June 20, 2025.
What is the P/E ratio for Baird Medical Investment Holdings stock?
The price to earnings (P/E) ratio for Baird Medical Investment Holdings (BDMD) stock is 13.24 as of June 20, 2025.
Does Baird Medical Investment Holdings stock pay dividends?
No, Baird Medical Investment Holdings (BDMD) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Baird Medical Investment Holdings dividend payment date?
Baird Medical Investment Holdings (BDMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Baird Medical Investment Holdings?
Baird Medical Investment Holdings (BDMD) has a beta rating of -0.93. This means that it has an inverse relation to market volatility.